申请人:Actelion Pharmaceutical Ltd.
公开号:US08044044B2
公开(公告)日:2011-10-25
The invention relates to compounds of formula (I) wherein R0 represents H or OH; R1 represents alkoxy; U and W represent N, V represents CH and R2 represents H or F, or U and V represent CH, W represents N and R2 represents H or F, or U and V represent N, W represents CH and R2 represents H, or U represents N, V represents CH, W represents CRa and R2 represents H; Ra represents CH2OH or alkoxycarbonyl; A represents the group CH═CH—B or a binuclear heterocyclic system D, B representing a mono- or di-substituted phenyl group wherein the substituents are halogen atoms and D representing one of the following groups wherein Z represents CH or N, and Q represents O or S; and to salts of such compounds. These compounds are useful as antibacterial agents.
本发明涉及式(I)的化合物,其中R0代表H或OH; R1代表烷氧基; U和W代表N,V代表CH,R2代表H或F,或U和V代表CH,W代表N,R2代表H或F,或U和V代表N,W代表CH,R2代表H,或U代表N,V代表CH,W代表CRa,R2代表H; Ra代表CH2OH或烷氧羰基; A代表CH═CH—B或一个双核杂环系统D,其中B代表一个单取代或双取代的苯基,取代基为卤素原子,D代表以下其中之一的基团,其中Z代表CH或N,Q代表O或S;以及这些化合物的盐。这些化合物可用作抗菌剂。